Mandate

Vinge advises Symphony Technology Group in connection with the public offer for IBS

May 18, 2011

Vinge advises Symphony Technology Group in connection with the public offer for IBS AB, listed on NASDAQ OMX First North. Symphony Technology Group offers SEK 1.75 in cash per share in IBS, regardless of share class, and the board of directors of IBS has unanimously recommended the shareholders to accept the offer. Shareholders representing approximately 75.5 percent of the shares and 81.4 percent of the votes have irrevocably undertaken to accept the offer.

Vinge’s team consists of partner in charge Pontus Enquist as well as Emil Hedberg. In addition, Fabian Ekeblad has advised on banking and finance issues, and Johan Mattsson, Maria Eierborg, Moa Bergsten, Mikael Satama Granberg, Per Westman and Anders Frick, among other, have participated in the due diligence carried out on IBS.

Related

Vinge advises Pricer AB in connection with its issuance of senior unsecured bonds and early redemption

Vinge advises Pricer AB (publ) in connection with its issuance of floating rate senior unsecured bonds of SEK 300 million within a framework of SEK 500 million and early redemption of existing bonds.
December 10, 2024

Vinge advises Carasent in connection with the listing on Nasdaq Stockholm

Vinge advises Carasent AB (publ) in connection with the listing on Nasdaq Stockholm. The listing is made through a reverse cross-border merger, whereby Carasent AB takes over Carasent ASA, previously listed on Oslo Stock Exchange.
December 09, 2024

Vinge has advised Apotea in connection with its listing on Nasdaq Stockholm

Vinge has advised Apotea AB (publ) (“Apotea”) in connection with its listing on Nasdaq Stockholm. The prospectus was published on November 26, 2024 and the first day of trading is December 6, 2024.
December 06, 2024